Enterotoxigenic Escherichia coli (ETEC) strains were isolated from travelers or military personnel who developed diarrhea after visiting Nepal or who were deployed to Thailand, Indonesia, or the Philippines. ETEC isolates were examined for colonization factor antigen (CFA). CFAs were identified on 59% (40 of 68) of the isolates examined. The lack of a detectable CFA on 41% (28 of 68) of the isolates is of concern for the development of an effective ETEC vaccine.
Enterotoxigenic Escherichia coli (ETEC) strains were isolated from travelers or military personnel who developed diarrhea after visiting Nepal or who were deployed to Thailand, Indonesia, or the Philippines. ETEC isolates were examined for colonization factor antigen (CFA). CFAs were identified on 59% (40 of 68) of the isolates examined. The lack of a detectable CFA on 41% (28 of 68) of the isolates is of concern for the development of an effective ETEC vaccine.
Enterotoxigenic Escherichia coli (ETEC) strains are a leading cause of diarrhea in travelers (10) and military personnel who are deployed to tropical developing countries (6) . ETEC strains produce a heat-labile and/or a heat-stable enterotoxin (LT and ST, respectively). Adherence of ETEC and colonization of the small intestine is recognized as an important, if not essential, early event in the development of ETEC-associated diarrhea (5) .
Colonization factor antigen (CFA) I (5) and putative colonization factor (PCF) O159:H4 (14) are terms that have been used to describe single fimbrial antigens. CFA II ETEC strains possess one or two other fimbrial coli surface (CS)-associated antigens. CFA II ETEC strains possess CS3 alone or in combination with CS1 or CS2 (2, 11); CFA IV ETEC strains have fimbrial antigen CS6 alone or together with CS4 or CS5 (13) .
Studies of ETEC have shown that each CFA or PCF is associated with a particular toxin type; for example, CFA I (5) and CFA II (11, 15) are associated with ST and LT or ST alone. CFAs have usually been described for ETEC strains that produced ST. McConnell et al. (8) described a novel CS17 antigen on strain O114:H21, which only produced LT.
In this study, we determined the prevalence of CFAs and CS antigens on ETEC strains acquired by travelers or expatriates with diarrhea living in Nepal and military personnel deployed to Indonesia, the Philippines, or Thailand for 1-month exercises.
(This study was approved by the Human Subjects Research Review Board of the Office of the U.S. Army Surgeon General. Written informed consent was obtained from each participant prior to enrollment in the study.)
Specimen collection. E. coli strains were isolated from expatriates with diarrhea and U.S. military personnel with diarrhea as previously described (6) . In Nepal, samples were obtained from travelers and expatriates seen at the Canadian International Water and Energy Clinic in Kathmandu. In Thailand, samples were collected from U.S. military personnel deployed to Utapao and Korat during the Cobra Gold 95 exercise. In Indonesia, samples were collected from U.S. military personnel with diarrhea deployed to Surabaya and Jakarta. In the Philippines, samples were from U.S. military personnel who developed diarrhea while deployed to Manila and Cebu city.
Travelers' diarrhea (TD) was defined as three or more unformed stools or two watery stools associated with abdominal cramps, an oral temperature of Ͼ37.5°C, vomiting, or anorexia. E. coli strains were isolated as previously described (6) . The stools from U.S. personnel in Indonesia and the Philippines were collected by Naval Medical Research Unit No. 2 personnel doing the 1995 Carat Cruise.
Determination of genes coding for enterotoxins. E. coli isolates were cultured on MacConkey plates and incubated at 37°C for 16 h. Thirty colonies and 4 controls were spotted on another plate. Controls included clinical isolates that have been shown to produce LT and ST, LT only, and ST only in functional assays in Bangkok. LT and ST E. coli B2C, LT-only E. coli K-12 pEWD299, ST-only E. coli K-12 pDAS100 (STIb), and pDAS101 (STIa) were used as gene controls. E. coli K-12 Xac that did not contain an ent plasmid was used as a negative control.
Whatman 541 filters (Millipore Corp., Bedford, Mass.) were placed over the colonies and processed as described by Maas (7). Filters were then hybridized with ␣-32 P-labeled LT and ST DNA probes (10 6 cpm) and exposed to X-Omat X-ray film with a Cronex intensification screen (Kodak, Rochester, N.Y.) at Ϫ70°C for 24 h. (4) . Colonies that hybridized with the LT and ST DNA probes were tested for enterotoxin production in the Y-1 adrenal (9) and suckling mouse (3) assays.
Determination of CFA and CS expression. A modification of the nitrocellulose replicate test (16) was used for the identification of ETEC CFA and CS antigens. Nitrocellulose (NC) filter papers (BA85; 0.45-m-pore size; Schleicher & Schuell, Keene, N.H.) were placed on Whatman no. 3 filter paper (Millipore Corp.) saturated with 10 mM phosphate buffer-0.15 M NaCl (pH 7.4). Isolates and controls were grown on colonization factor agar (5) overnight at 37°C and suspended in 1 ml of phosphate-buffered saline; 2 l of this culture was spot-ted on nine different NC filters, and the filters were air dried for 15 to 30 min. The NC filters were then washed with TBS (20 mM Tris-HCl [pH 7.5], 0.5 M NaCl)-0.05% Tween 20 in TBS twice for 10 min. The filter was then blocked with TBS with 1% bovine serum albumin (BSA) and 0.05% Tween 20 at 25°C for 30 min. Positive and negative controls (strain names follow in parentheses) for the replicate plate test included the following for CFA I (258909-3): CS1 (60R75), CS2 (C91f), CS3 (E9034A), CS4 (E11881A), CS5 (E17018A), CS6 (E11881/14), CS7 (E29101A), CS17 (E20738A), PCFO159 (3501A), and PCFO166 (E7476A). Negative controls included the following for CFA I (250809-3M): CS5 (E170183), CS6 (E1581/2), CS7 (E29101B), CS17 (E20738B), PCFO159 (3501B), and PCFO166 (E7476B). CS1 to CS4, CS-negative controls used the same isolates as the positive controls, but the strains were grown at 18°C rather than at 37°C on CFA agar for 24 h.
The blocking solution was then discarded, and 5 ml of mouse monoclonal antibodies (MAbs) to CFA I, CS1, CS2, CS3, CS4, CS5, CS7, CS17, PCFO159, and PCFO166 were added. All MAbs diluted 1:250 or rabbit polyclonal antibody to CS6 diluted 1:2,500 in TBS with 0.1% BSA and 0.05% Tween 20 were incubated at 25°C for 2 h. Rabbit antiserum to CS6 was produced by immunization of rabbits with CS6-positive E. coli E11881/14 (O26:H42) and absorbtion with E. coli 11881/2, a CS6-negative mutant, as described by Smyth (11).
The NC filters were then washed three times for 5 min each in TBS-Tween. Horseradish peroxidase-labeled anti-mouse or anti-rabbit immunoglobulin G antibodies diluted 1:200 in TBS with 0.1% BSA and 0.05% Tween 20 were then added. The NC filters were incubated at 25°C for 1 h, and then the NC filters were washed three times for 5 min in TBS-Tween 20 and once in TBS.
The filters were then placed in 4-chloro-1-napthol-H 2 O 2 for 10 min (4 chloro-1-napthol-H 2 O 2 consisted of 6 mg of 4-chloro-1-napthol, 2 ml of methanol alcohol, 10 ml of TBS [pH 7.5], and 4 l of 35% H 2 O 2 ). The reaction was stopped by washing the filters with TBS and air drying. The filters were read immediately or were stored in the dark until photographed.
The prevalences of ETEC isolated from stool samples from persons with TD were 24% (19 of 80) among military personnel after deployment to Indonesia, 13% (26 of 207) among travelers in Nepal, 10% (4 of 40) among military personnel deployed to the Philippines, and 10% (19 of 191) among military personnel deployed to Thailand. The CFA and CS antigens associated with ETEC that produced different types of toxin are shown in Table 1 . The prevalences of toxin types that expressed CFA and CS antigens by country are shown in Table  2 .
Besides the production of enterotoxins, at least one other important virulence factor, the ability to adhere to the intestinal mucosa by fimbria-like adhesins, has been recognized (5). This study was performed to identify antigens that could be used to immunize travelers visiting Asia against ETEC infections. Immunization with LT toxoid has been reported to increase the efficacy of a vaccine to reduce LT and ST and LT-only ETEC infections (1). However, the duration of immunity to LT is short-lived, and current vaccines are based on CFA and CS antigens.
In this study, 41% of ETEC isolates detected among patients with TD did not express known CFA or CS antigens. The ETEC strains from Thailand were unusual in their lack of defined CFAs. Other studies have found that CFAs are expressed in a higher proportion of ETEC strains than we report in Thailand, where ETEC strains lacking defined CFAs tend to express ST only.
These data suggest that ETEC strains associated with TD in these four locations, and Thailand in particular, lack antigens present in the vaccine currently in field trials. These data point to the need to survey for toxins and CFAs and the necessity of continuing to identify new CFAs.
Although the ETEC isolates were collected from patients with TD in four different developing countries, it does not follow that the CFA or CS antigens detected in this single study can totally predict future CFAs on ETEC infections in Asia. Stoll et al. (12) showed that the serotype of ETEC in Bangladesh varied from season to season and year to year. A vaccine designed for use in travelers visiting Asia should be based on studies conducted in various populations over several years. 
